Publications
Scientific rigor is central to everything we do at Ernexa Therapeutics. Explore our published studies to learn more about the science behind our cell therapy platform and the data driving our work in oncology and autoimmune disease.
Any Year
Cancer Res, Vol 85, (8_Supplement_1): 3473, 2025
iPS-derived MSC secreting IL7 and IL15 exert immune mediated anti-tumor activities
Download PDF Poster J Clin Oncol, Vol 43, (16_suppl): 2538, 2025
Engineering iPSC-derived mesenchymal stem cells (iMSCs) to secrete IL-7/IL-15 for modulation of the tumor microenvironment in a “cold” ovarian tumor model
Download PDF Poster Mol Ther, Vol 32, No 4S1, 2024
Targeted Insertion of HLA-E at the B2M Locus of mRNA-Reprogrammed iPSCs Facilitates the Development of Allogeneic Cell Therapies with Enhanced Safety Features
Download PDF Poster Mol Ther, Vol 32, No 4S1, 2024
Sustained Transgene Expression in Engineered iPSC-Derived Tissue-Specific Cells
Download PDF Poster ASGCT Poster, 2024
iPSC-Derived Macrophages Engineered to Express IL-12 Enhance Cancer Cell Killing of a Multi-Cell Type Therapeutic Platform
Download PDF Poster ISSCR Poster, 2024
B2M-KO iMSCs Better Suppress T Cell Proliferation by Upregulating IDO1 in Response to Proinflammatory Signals
Download PDF Poster